Trump’s Approval of AI Chip Sales to China Triggers Bipartisan National Security Concerns 
Asian Currencies Steady as Fed Delivers Hawkish Rate Cut; Aussie and Rupee Under Pressure 
Apple App Store Injunction Largely Upheld as Appeals Court Rules on Epic Games Case 
Ireland Limits Planned Trade Ban on Israeli Settlements to Goods Only 
SoftBank Shares Slide as Oracle’s AI Spending Plans Fuel Market Jitters 
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition 
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025 
SoftBank Eyes Switch Inc as It Pushes Deeper Into AI Data Center Expansion 
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff 
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate 
Gold Prices Hold Firm as Markets Await Fed Rate Cut; Silver Surges to Record High 
Oil Prices Rebound in Asia as Venezuela Sanctions Risks Offset Ukraine Peace Hopes 
Wall Street Futures Slip as Oracle Earnings Miss Reignites AI Spending Concerns 
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths 
Mexico Moves to Increase Tariffs on Asian Imports to Protect Domestic Industries 
ADB Approves $400 Million Loan to Boost Ease of Doing Business in the Philippines 
GameStop Misses Q3 Revenue Estimates as Digital Shift Pressures Growth 
An Abbott Laboratories processing plant in Sturgis, Mich being investigated for cases of infant illness is being allowed to release some product that was processed before it was shut down.
Certain goods designed for infants and people with specific medical issues will be given out for free.
Abbott officials claimed they're doing it at the FDA's request to help with shortages of these specialty feeding items.
After a recall of Similac infant formula and other products in February, the Sturgis plant was forced to shut down. Cronobacter bacteria had infected many infants, one of whom died; cronobacter was identified in their systems and the formula they had drunk. Cronobacter bacteria were discovered in the factory during an inspection.
However, further examination revealed that the cronobacter strain that caused the infections was not the same as the one detected in the plant and that no food-contact surfaces had been contaminated.
On a case-by-case basis, Abbott is issuing cases of a nutrition supplement for people with uncommon metabolic diseases and others. The corporation stated that it is doing so at the FDA's request to assist reduce shortages.
